Delaware Attorney General Kathleen Jennings announced Thursday a multistate settlement with Johnson & Johnson and its subsidiary, Ethicon, Inc., for their deceptive marketing of transvaginal surgical mesh devices. A multistate investigation found the companies violated state consumer protection laws by misrepresenting the safety and effectiveness of the devices and failing to sufficiently disclose risks associated […]
Delaware Joins 44 Other States and District of Columbia in Settlement Over Misleading Information Regarding Hip Implants
Delaware Attorney General Kathy Jennings announced Friday that she and 45 other Attorneys General reached a settlement with Johnson & Johnson and its subsidiary DePuy Orthopaedics, Inc., to resolve allegations that DePuy unlawfully promoted two of its metal-on-metal hip implant devices. Attorneys General allege that DePuy engaged in deceptive practices in its promotion of the […]
Delaware Joins Other States in Settlement With Pharmaceutical Company Regarding the Marketing of Over-The-Counter Drugs
Forty-three states, including Delaware, have reached a settlement with Johnson & Johnson Consumer Inc. and Johnson & Johnson over allegations that the manufacturers inaccurately promoted their over-the-counter (OTC) drugs as complying with federally mandated current Good Manufacturing Practices despite some manufacturing facilities did not comply. The state alleged that between 2009 and 2011, McNeil Consumer […]
Attorney General Beau Biden announced today that the state will be paid $2 million by Johnson & Johnson as part of national settlement to resolve allegations that the New Jersey-based pharmaceutical manufacturer fraudulently marketed the antipsychotic drugs Risperdal and Invega.